A modelling study shows the six-monthly anti-HIV jab, lenacapavir, could end Aids in SA by 2032 - but only if between two and ...

A modelling study shows that lenacapavir could end Aids in South Africa by 2032 – but only if between two and four million ...

Paediatric and syrup formulations: Zidovudine/Lamivudine tablet stock is high (25.27 months of stock). Nevirapine syrup is fully available (6.38 MoS), there are lower stock levels of Zidovudine syrup ...

The reduction or elimination of funding from the US President's Emergency Plan for AIDS Relief (PEPFAR) could lead to the ...

In Malawi, the Government’s 2025-26 budget has allocated 23.3 billion Malawian Kwacha (US$13.3 million) to the Ministry of Health and plans to hire 6,000 workers to mitigate the impact of the US ...

PEPFAR (President's Emergency Plan for AIDS Relief), a landmark US foreign health policy, is recognised for saving 26 million ...

We express our great appreciation to the American people and US Government for the incredible support through the President's Emergency Plan for AIDS Relief (PEPFAR), or any other new programme that ...

South African scientists announce promising results from an HIV-cure trial, showing hope for long-term virus control without ...

The future of funding for global health programmes like those detecting and treating HIV/Aids are in peril after funding cuts.

U.S. aid allowed Mary, a former sex worker, to do HIV outreach work and support eight children. Her future, and the U.S.-led ...

Since U.S. President Donald Trump froze funds under the President's Emergency Plan for AIDS Relief (PEPFAR) in January, even ...

Countries located in sub-Saharan Africa would be most affected by all funding cuts to the international HIV response.